Cancer Genetics Inc (CGIX) COO Acquires $24,400.00 in Stock
Cancer Genetics Inc (NASDAQ:CGIX) COO John A. Roberts acquired 12,200 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was purchased at an average price of $2.00 per share, for a total transaction of $24,400.00. Following the acquisition, the chief operating officer now directly owns 12,200 shares in the company, valued at approximately $24,400. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Cancer Genetics Inc (CGIX) traded up $0.10 during midday trading on Thursday, hitting $2.05. The stock had a trading volume of 160,300 shares, compared to its average volume of 256,601. Cancer Genetics Inc has a fifty-two week low of $1.30 and a fifty-two week high of $5.30. The company has a debt-to-equity ratio of 0.18, a quick ratio of 2.01 and a current ratio of 2.01.
CGIX has been the topic of several analyst reports. HC Wainwright reiterated a “buy” rating and set a $6.00 price target on shares of Cancer Genetics in a report on Thursday, September 21st. Maxim Group set a $6.00 price target on Cancer Genetics and gave the stock a “buy” rating in a report on Wednesday, December 13th. Zacks Investment Research upgraded Cancer Genetics from a “sell” rating to a “hold” rating in a report on Wednesday, November 29th. Finally, ValuEngine lowered Cancer Genetics from a “hold” rating to a “sell” rating in a report on Friday, September 1st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company’s stock. Cancer Genetics presently has a consensus rating of “Hold” and an average price target of $5.56.
Cancer Genetics Company Profile
Cancer Genetics, Inc is a United States-based company, which is engaged in the field of personalized medicine. The Company offers diagnostic products and services that enable precision medicine in the field of oncology through molecular markers and diagnostics. The Company offers a range of laboratory services that provide genomic and biomarker information.
Receive News & Ratings for Cancer Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cancer Genetics and related companies with MarketBeat.com's FREE daily email newsletter.